Chinese General Practice ›› 2023, Vol. 26 ›› Issue (23): 2848-2853.DOI: 10.12114/j.issn.1007-9572.2023.0148
Special Issue: 内分泌代谢性疾病最新文章合辑; 老年人群健康最新文章合辑; 衰弱最新文章合辑; 胰腺炎最新文章合辑; 老年问题最新文章合辑
• Original Research·Elderly Frailty Research • Previous Articles Next Articles
Received:
2023-03-22
Revised:
2023-04-06
Published:
2023-08-15
Online:
2023-04-20
Contact:
WANG Xiaoyun
通讯作者:
王晓云
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0148
组别 | 例数 | 性别〔n(%)〕 | 年龄(岁) | 文化程度〔n(%)〕 | 婚姻状况〔n(%)〕 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 小学及以下 | 初中 | 中专/高中 | 大专 | 本科及以上 | 非在婚 | 在婚 | |||
对照组 | 39 | 18(46.2) | 21(53.8) | 67.4±2.8 | 12(30.8) | 8(20.5) | 10(25.6) | 6(15.4) | 3(7.7) | 10(25.6) | 29(74.4) |
试验组 | 40 | 13(32.5) | 27(67.5) | 67.5±3.1 | 9(22.5) | 10(25.0) | 15(37.5) | 4(10.0) | 2(5.0) | 7(17.5) | 33(82.5) |
检验统计量值 | 1.544 | 0.212a | -0.162b | 0.775 | |||||||
P值 | 0.214 | 0.832 | 0.871 | 0.379 | |||||||
组别 | 居住状况〔n(%)〕 | 个人月收入〔n(%)〕 | 医保类型〔n(%)〕 | 合并慢性病数量〔M(P25,P75),种〕 | |||||||
非独居 | 独居 | <1 000元 | 1 000~2 999元 | 3 000~5 000元 | >5 000元 | 医保 | 新农合 | ||||
对照组 | 28(71.8) | 11(28.2) | 9(23.1) | 11(28.2) | 10(25.6) | 9(23.1) | 22(56.4) | 17(43.6) | 2.0(2.0,3.0) | ||
试验组 | 32(80.0) | 8(20.0) | 5(12.5) | 10(25.0) | 11(27.5) | 14(35.0) | 25(62.5) | 15(37.5) | 2.0(1.0,3.0) | ||
检验统计量值 | 0.728 | -1.478b | 0.304 | -1.292b | |||||||
P值 | 0.394 | 0.140 | 0.581 | 0.196 |
Table 1 Comparison of general data between the two groups
组别 | 例数 | 性别〔n(%)〕 | 年龄(岁) | 文化程度〔n(%)〕 | 婚姻状况〔n(%)〕 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 小学及以下 | 初中 | 中专/高中 | 大专 | 本科及以上 | 非在婚 | 在婚 | |||
对照组 | 39 | 18(46.2) | 21(53.8) | 67.4±2.8 | 12(30.8) | 8(20.5) | 10(25.6) | 6(15.4) | 3(7.7) | 10(25.6) | 29(74.4) |
试验组 | 40 | 13(32.5) | 27(67.5) | 67.5±3.1 | 9(22.5) | 10(25.0) | 15(37.5) | 4(10.0) | 2(5.0) | 7(17.5) | 33(82.5) |
检验统计量值 | 1.544 | 0.212a | -0.162b | 0.775 | |||||||
P值 | 0.214 | 0.832 | 0.871 | 0.379 | |||||||
组别 | 居住状况〔n(%)〕 | 个人月收入〔n(%)〕 | 医保类型〔n(%)〕 | 合并慢性病数量〔M(P25,P75),种〕 | |||||||
非独居 | 独居 | <1 000元 | 1 000~2 999元 | 3 000~5 000元 | >5 000元 | 医保 | 新农合 | ||||
对照组 | 28(71.8) | 11(28.2) | 9(23.1) | 11(28.2) | 10(25.6) | 9(23.1) | 22(56.4) | 17(43.6) | 2.0(2.0,3.0) | ||
试验组 | 32(80.0) | 8(20.0) | 5(12.5) | 10(25.0) | 11(27.5) | 14(35.0) | 25(62.5) | 15(37.5) | 2.0(1.0,3.0) | ||
检验统计量值 | 0.728 | -1.478b | 0.304 | -1.292b | |||||||
P值 | 0.394 | 0.140 | 0.581 | 0.196 |
组别 | 例数 | 基线 | 干预6周 | 干预12周 | Wald χ2值 | P值 |
---|---|---|---|---|---|---|
对照组 | 39 | 22(20,23) | 22(21,23)a | 21(21,22)ab | 24.078 | <0.001 |
试验组 | 40 | 22(22,23) | 23(22,23) | 24(23,25)ab | 150.179 | <0.001 |
Wald χ2值 | 0.608 | 2.471 | 47.410 | |||
P值 | 0.435 | 0.116 | <0.001 |
Table 2 Comparison of MoCA score between the two groups
组别 | 例数 | 基线 | 干预6周 | 干预12周 | Wald χ2值 | P值 |
---|---|---|---|---|---|---|
对照组 | 39 | 22(20,23) | 22(21,23)a | 21(21,22)ab | 24.078 | <0.001 |
试验组 | 40 | 22(22,23) | 23(22,23) | 24(23,25)ab | 150.179 | <0.001 |
Wald χ2值 | 0.608 | 2.471 | 47.410 | |||
P值 | 0.435 | 0.116 | <0.001 |
组别 | 例数 | FP评分(分) | 步速(m/s) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
基线 | 干预6周 | 干预12周 | Waldχ2值 | P值 | 基线 | 干预6周 | 干预12周 | Waldχ2值 | P值 | ||
对照组 | 39 | 3(2,3) | 3(3,3) | 3(3,4)ab | 18.759 | <0.001 | 0.71(0.62,0.77) | 0.70(0.59,0.73)a | 0.67(0.56,0.71)ab | 184.445 | <0.001 |
试验组 | 40 | 3(2,3) | 2(2,3)a | 2(1,2)ab | 241.397 | <0.001 | 0.67(0.57,0.78) | 0.71(0.62,0.82)a | 0.78(0.69,0.87)ab | 384.314 | <0.001 |
Waldχ2值 | 0.025 | 15.041 | 66.476 | 0.408 | 3.469 | 32.143 | |||||
P值 | 0.874 | <0.001 | <0.001 | 0.523 | 0.063 | <0.001 | |||||
组别 | 握力(kg) | ||||||||||
基线 | 干预6周 | 干预12周 | Waldχ2值 | P值 | |||||||
对照组 | 20.20(17.20,27.00) | 19.40(16.20,26.20)a | 19.30(16.00,26.00)ab | 2 463.486 | <0.001 | ||||||
试验组 | 18.50(16.30,27.75) | 19.75(17.53,28.85)a | 20.70(18.28,29.88)ab | 6 003.341 | <0.001 | ||||||
Waldχ2值 | 0.185 | 1.474 | 4.735 | ||||||||
P值 | 0.667 | 0.225 | 0.030 |
Table 3 Comparison of frailty indicators between the two groups
组别 | 例数 | FP评分(分) | 步速(m/s) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
基线 | 干预6周 | 干预12周 | Waldχ2值 | P值 | 基线 | 干预6周 | 干预12周 | Waldχ2值 | P值 | ||
对照组 | 39 | 3(2,3) | 3(3,3) | 3(3,4)ab | 18.759 | <0.001 | 0.71(0.62,0.77) | 0.70(0.59,0.73)a | 0.67(0.56,0.71)ab | 184.445 | <0.001 |
试验组 | 40 | 3(2,3) | 2(2,3)a | 2(1,2)ab | 241.397 | <0.001 | 0.67(0.57,0.78) | 0.71(0.62,0.82)a | 0.78(0.69,0.87)ab | 384.314 | <0.001 |
Waldχ2值 | 0.025 | 15.041 | 66.476 | 0.408 | 3.469 | 32.143 | |||||
P值 | 0.874 | <0.001 | <0.001 | 0.523 | 0.063 | <0.001 | |||||
组别 | 握力(kg) | ||||||||||
基线 | 干预6周 | 干预12周 | Waldχ2值 | P值 | |||||||
对照组 | 20.20(17.20,27.00) | 19.40(16.20,26.20)a | 19.30(16.00,26.00)ab | 2 463.486 | <0.001 | ||||||
试验组 | 18.50(16.30,27.75) | 19.75(17.53,28.85)a | 20.70(18.28,29.88)ab | 6 003.341 | <0.001 | ||||||
Waldχ2值 | 0.185 | 1.474 | 4.735 | ||||||||
P值 | 0.667 | 0.225 | 0.030 |
组别 | 例数 | 基线 | 干预12周 | t配对值 | P值 |
---|---|---|---|---|---|
对照组 | 39 | 8.89±1.48 | 8.76±1.50 | 4.951 | <0.001 |
试验组 | 40 | 8.57±1.41 | 8.07±1.36 | 17.865 | <0.001 |
t值 | 0.975 | 2.139 | |||
P值 | 0.332 | 0.036 |
Table 4 Comparison of HbA1c level between the two groups
组别 | 例数 | 基线 | 干预12周 | t配对值 | P值 |
---|---|---|---|---|---|
对照组 | 39 | 8.89±1.48 | 8.76±1.50 | 4.951 | <0.001 |
试验组 | 40 | 8.57±1.41 | 8.07±1.36 | 17.865 | <0.001 |
t值 | 0.975 | 2.139 | |||
P值 | 0.332 | 0.036 |
[1] |
|
[2] |
孔令磷,赵慧敏,刘玥婷,等. 社区老年2型糖尿病患者认知衰弱现状及影响因素[J]. 护理学杂志,2020,35(7):89-92. DOI:10.3870/j.issn.1001-4152.2020.07.089.
|
[3] |
张爽,陈影,姜宗良,等. 社区老年糖尿病患者认知衰弱现状及影响因素分析[J]. 中国护理管理,2020,20(3):383-388. DOI:10.3969/j.issn.1672-1756.2020.03.014.
|
[4] |
刘泳秀,韩婷,余莉,等. 老年2型糖尿病患者认知衰弱现状及影响因素研究[J]. 中国慢性病预防与控制,2021,29(6):426-431. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.06.006.
|
[5] |
|
[6] |
|
[7] | |
[8] |
|
[9] |
|
[10] |
葛均波,徐永健,王辰. 内科学[M]. 9版. 北京:人民卫生出版社,2018:733.
|
[11] |
|
[12] |
湾明月. 基于海马亚区体积探索八段锦改善认知衰弱症的机制[D]. 福州:福建中医药大学,2021.
|
[13] |
国家体育总局健身气功管理中心. 健身气功·八段锦[M]. 北京:人民体育出版社,2003.
|
[14] |
葛守萍. 中老年保健操(手指操)[EB/OL]. (2019-10-24)[2022-12-31].
|
[15] |
范静波,卢国华,张莹莹,等. 团体认知干预对社区MCI老人认知功能的影响[J]. 中国护理管理,2013,13(11):70-72. DOI:10.3969/j.issn.1672-1756.2013.011.022.
|
[16] |
|
[17] |
虎子颖,赵志刚,张会峰,等. 2型糖尿病患者轻度认知功能障碍与海马体积及血清抵抗素的相关性研究[J]. 中国糖尿病杂志,2015,23(4):331-333. DOI:10.3969/j.issn.1006-6187.2015.04.013.
|
[18] |
陈婉君. 2型糖尿病患者认知功能的流行病学特点及筛查工具研究[D]. 重庆:重庆医科大学,2012.
|
[19] |
|
[20] |
应巧燕,刘华平,郭欣颖,等. 老年人衰弱筛查和评估的证据总结[J]. 护理学杂志,2017,32(1):95-98. DOI:10.3870/j.issn.1001-4152.2017.01.095.
|
[21] |
张爽,陈影,孙娜雅,等. 综合运动训练对老年糖尿病患者衰弱和躯体功能的影响[J]. 中华护理杂志,2020,55(10):1445-1451. DOI:10.3761/j.issn.0254-1769.2020.10.001.
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
认知训练中国专家共识写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会. 认知训练中国专家共识[J]. 中华医学杂志,2019,99(1):4-8. DOI:10.3760/cma.j.issn.0376-2491.2019.01.002.
|
[28] |
|
[29] | |
[30] | |
[31] |
王梅杰,廖春满,张正媚,等. 八段锦对2型糖尿病患者血糖血脂水平等辅助治疗效果影响的Meta分析[J]. 北京中医药,2021,40(2):179-184. DOI:10.16025/j.1674-1307.2021.02.019.
|
[32] |
高志鹏. 八段锦对衰弱前期老年人衰弱状态及下肢运动功能的康复效果[D]. 唐山:华北理工大学,2020.
|
[33] |
韩君,王君俏,高键,等. 弹力带运动联合认知训练对社区老年人认知衰弱的干预效果[J]. 护理研究,2022,36(4):624-629. DOI:10.12102/j.issn.1009-6493.2022.04.010.
|
[34] |
魏璐璐,朱泓吉,朱琳,等. 八段锦对2型糖尿病患者血糖影响的meta分析[J]. 湘南学院学报,2021,42(5):71-75,95. DOI:10.3969/j.issn.1672-8173.2021.05.013.
|
[35] |
|
[1] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[2] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[3] | CHENG Yuxin, FANG Jiamin, LIANG Hao, WANG Zhiling, WEI Li, LIAO Huilian, XU Mingming, CHEN Yumei, LI Yanfen, DONG Lijuan, GUO Yingui. Preoperative Platelet-to-albumin Ratio in Elective Geriatric Surgery Patients and Its Correlation with Postoperative Incidental Frailty: a Multicenter Study [J]. Chinese General Practice, 2025, 28(27): 3359-3367. |
[4] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[5] | ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270. |
[6] | ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei. Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy [J]. Chinese General Practice, 2025, 28(26): 3307-3313. |
[7] | TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang. Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3096-3103. |
[8] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[9] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[10] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[11] | YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004. |
[12] | BAI Xue, CHEN Qianqian, LI Jie. Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2841-2845. |
[13] | WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei. Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(23): 2846-2851. |
[14] | LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin. Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2852-2860. |
[15] | LIU Meixia, YIN Jinnian, WU Mei, YANG Xing, ZHOU Quanxiang, YANG Jingyuan. Impact of Body Mass Index on the Association of Triglyceride Glucose Index with Cognitive Function: a Cross-sectional Study in Rural Older Adults in Guizhou Province [J]. Chinese General Practice, 2025, 28(22): 2806-2812. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||